Braintree Health

Braintree Health EMR / clinical platform

Braintree Health · Review dated 2026-10-13

No public dollar amount, currency, or numeric plan price was found on the reviewed official Braintree pages/documents. The official January 2026 ONC transparency disclosure says the Braintree Ambulatory Version 10.5.1.1 base service agreement includes an annual licensing and subscription fee for immunization registries, syndromic surveillance, reportable lab results, electronic case reporting, health-care surveys, clinical quality measures, encryption/MFA, and EHI export. It separately states that a Direct messaging account for each provider will be charged and that electronic-prescribing accounts/licenses are charged per provider, but gives no amounts. Therefore pricing is not publicly quantified and should be treated as quote/base-agreement pricing.

Billing model

Base-service-agreement model with an annual licensing/subscription fee; exact amount and whether the base is per clinician, location, practice, or enterprise are not disclosed. Certain capabilities have provider-level charges (Direct account and e-prescription license).

Fees and add-ons

Official ONC disclosures: additional e-prescription license fee per provider; Direct messaging account charged for each provider. The January 2026 transparency page lists the annual licensing/subscription fee as included in the base service agreement for multiple public-health, CQM, security, and EHI-export capabilities, with no separate additional costs stated. No public implementation, setup, training, interface, migration, storage, or support dollar fees were found. BMW Platform marketing says customizable reports/clinical codes and practice-analysis reports are included at no extra cost, and describes built-in support, but does not quantify implementation/support pricing.

Availability and public pricing

Current U.S. availability appears likely: Braintree’s official About page says Braintree LLC was founded in 2004, is based in Texas, and Braintree Products sells directly to end-user healthcare markets including specialty clinics in the US and Canada. The official site remains accessible and presents the BMW Platform/BrainTREE ambulatory EMR/PACS, current contact details, and a January 2026 transparency document. No acquisition, rename, or discontinuation evidence was found; product identity is presented across official pages as BMW Platform, BrainTREE, and Braintree Ambulatory Version 10.5.1.1.

Qualifications

Status is not explicitly dated as an active sales announcement; the certification pages cite product certifications dated 2019 and November 19, 2021, while marketing pages are largely undated. The January 2026 transparency document supports ongoing official maintenance but still does not establish exact commercial pricing or contract terms. The product is broader than a general ambulatory EHR, combining EMR, PACS, RIS, ERP, procedure workflows, portals, billing/reporting, and interoperability.